Henry A. Fernandez's most recent trade in MSCI Inc was a trade of 3,190 Common Stock done at an average price of $535.5 . Disclosure was reported to the exchange on Dec. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 535.51 per share. | 05 Dec 2025 | 3,190 | 1,482,554 (1%) | 0% | 535.5 | 1,708,277 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 536.34 per share. | 05 Dec 2025 | 1,892 | 1,484,446 (1%) | 0% | 536.3 | 1,014,755 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 533.12 per share. | 05 Dec 2025 | 1,124 | 1,478,321 (1%) | 0% | 533.1 | 599,227 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 539.57 per share. | 05 Dec 2025 | 1,106 | 1,486,487 (1%) | 0% | 539.6 | 596,764 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 534.55 per share. | 05 Dec 2025 | 1,043 | 1,479,364 (1%) | 0% | 534.6 | 557,536 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 536.02 per share. | 05 Dec 2025 | 552 | 334,278 (0%) | 0% | 536.0 | 295,883 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 535.10 per share. | 05 Dec 2025 | 547 | 333,726 (0%) | 0% | 535.1 | 292,700 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 538.77 per share. | 05 Dec 2025 | 504 | 1,485,381 (1%) | 0% | 538.8 | 271,540 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 540.46 per share. | 05 Dec 2025 | 480 | 1,486,967 (1%) | 0% | 540.5 | 259,421 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 537.31 per share. | 05 Dec 2025 | 431 | 1,484,877 (1%) | 0% | 537.3 | 231,581 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 531.98 per share. | 05 Dec 2025 | 360 | 1,477,197 (1%) | 0% | 532.0 | 191,513 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 536.90 per share. | 05 Dec 2025 | 317 | 334,595 (0%) | 0% | 536.9 | 170,197 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 533.22 per share. | 05 Dec 2025 | 260 | 333,179 (0%) | 0% | 533.2 | 138,637 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 540.37 per share. | 05 Dec 2025 | 240 | 335,029 (0%) | 0% | 540.4 | 129,689 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 532.37 per share. | 05 Dec 2025 | 140 | 332,919 (0%) | 0% | 532.4 | 74,532 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 539.35 per share. | 05 Dec 2025 | 114 | 334,789 (0%) | 0% | 539.4 | 61,486 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 537.75 per share. | 05 Dec 2025 | 80 | 334,675 (0%) | 0% | 537.8 | 43,020 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 541.22 per share. | 05 Dec 2025 | 80 | 1,487,047 (1%) | 0% | 541.2 | 43,298 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 541.90 per share. | 05 Dec 2025 | 40 | 335,069 (0%) | 0% | 541.9 | 21,676 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 544.70 per share. | 24 Jul 2025 | 9,916 | 1,279,867 (1%) | 0% | 544.7 | 5,401,245 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 535.11 per share. | 24 Jul 2025 | 2,400 | 332,779 (0%) | 0% | 535.1 | 1,284,264 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 550.42 per share. | 24 Jul 2025 | 43 | 1,279,951 (1%) | 0% | 550.4 | 23,668 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 546.39 per share. | 24 Jul 2025 | 23 | 1,279,890 (1%) | 0% | 546.4 | 12,567 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 547.50 per share. | 24 Jul 2025 | 18 | 1,279,908 (1%) | 0% | 547.5 | 9,855 | Common Stock |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 35.24 per share. | 30 Jun 2025 | 1,064 | 65,324 | - | 35.2 | 37,495 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 7,614 | 64,260 | - | 0 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | Grant, award, or other acquisition of securities at price $ 32.87 per share. | 31 Mar 2025 | 1,141 | 56,646 | - | 32.9 | 37,500 | Class A Ordinary Shares |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 574.98 per share. | 24 Feb 2025 | 4,700 | 1,269,851 (1%) | 0% | 575.0 | 2,702,406 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 569.86 per share. | 24 Feb 2025 | 500 | 1,265,151 (1%) | 0% | 569.9 | 284,930 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 575.66 per share. | 24 Feb 2025 | 100 | 1,269,951 (1%) | 0% | 575.7 | 57,566 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 58,370 | 1,296,930 (1%) | 0% | 0 | Common Stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 587.48 per share. | 06 Feb 2025 | 32,279 | 1,264,651 (1%) | 0% | 587.5 | 18,963,267 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 44,920 | 44,920 | - | - | Premium option to purchase common stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 40,780 | 40,780 | - | - | Premium option to purchase common stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 36,846 | 36,846 | - | - | Premium option to purchase common stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 29,564 | 29,564 | - | - | Option to purchase common stock | |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 31 Dec 2024 | 1,503 | 55,505 | - | 24.9 | 37,487 | Class A Ordinary Shares | |
| MSCI | Fernandez A. Henry | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 613.38 per share. | 05 Dec 2024 | 1,807 | 329,886 (0%) | 0% | 613.4 | 1,108,378 | Common Stock |
| MSCI | A. Henry Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 610.00 per share. | 05 Dec 2024 | 600 | 328,079 (0%) | 0% | 610 | 366,000 | Common Stock |
| MSCI | A. Henry Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 614.08 per share. | 05 Dec 2024 | 493 | 330,379 (0%) | 0% | 614.1 | 302,741 | Common Stock |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 30 Sep 2024 | 1,342 | 54,002 | - | 27.9 | 37,475 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 28 Jun 2024 | 1,399 | 52,660 | - | 26.8 | 37,493 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 07 Jun 2024 | 9,293 | 51,261 | - | 0 | Class A Ordinary Shares | ||
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Apr 2024 | 7,500 | 15,400 (0%) | 0% | 0 | Common Stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Apr 2024 | 7,500 | 15,400 (0%) | 0% | 0 | Common Stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Apr 2024 | 7,500 | 1,760,267 (2%) | 0% | 0 | Common Stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Apr 2024 | 7,500 | 15,400 (0%) | 0% | 0 | Common Stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Apr 2024 | 7,500 | 1,745,267 (2%) | 0% | 0 | Common Stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Apr 2024 | 7,500 | 1,752,767 (2%) | 0% | 0 | Common Stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 468.52 per share. | 25 Apr 2024 | 4,294 | 325,835 (0%) | 0% | 468.5 | 2,011,825 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 469.66 per share. | 25 Apr 2024 | 1,644 | 327,479 (0%) | 0% | 469.7 | 772,121 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 464.55 per share. | 25 Apr 2024 | 1,600 | 319,793 (0%) | 0% | 464.6 | 743,280 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 461.92 per share. | 25 Apr 2024 | 1,445 | 317,330 (0%) | 0% | 461.9 | 667,474 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 467.24 per share. | 25 Apr 2024 | 988 | 321,541 (0%) | 0% | 467.2 | 461,633 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 460.69 per share. | 25 Apr 2024 | 906 | 315,885 (0%) | 0% | 460.7 | 417,385 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 462.96 per share. | 25 Apr 2024 | 863 | 318,193 (0%) | 0% | 463.0 | 399,534 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 465.74 per share. | 25 Apr 2024 | 760 | 320,553 (0%) | 0% | 465.7 | 353,962 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 459.48 per share. | 25 Apr 2024 | 500 | 314,979 (0%) | 0% | 459.5 | 229,740 | Common Stock |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 28 Mar 2024 | 1,240 | 41,968 | - | 30.2 | 37,483 | Class A Ordinary Shares | |
| MSCI | A. Henry Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 84,022 | 1,559,427 (1%) | 0% | 0 | Common Stock | |
| MSCI | A. Henry Fernandez | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 583.39 per share. | 05 Feb 2024 | 46,465 | 1,512,962 (1%) | 0% | 583.4 | 27,107,216 | Common Stock |
| MSCI | Henry Fernandez A. | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 7,298 | 1,520,260 (1%) | 0% | 0 | Common Stock | |
| MSCI | A. Henry Fernandez | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 583.39 per share. | 05 Feb 2024 | 4,036 | 1,516,224 (1%) | 0% | 583.4 | 2,354,562 | Common Stock |
| Royalty Pharma PLC (Class A) | A. Fernandez Henry | Director | 29 Dec 2023 | 1,353 | 40,728 | - | 27.7 | 37,493 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 30 Jun 2023 | 1,208 | 37,991 | - | 31.0 | 37,481 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 23 Jun 2023 | 7,747 | 36,783 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 31 Mar 2023 | 1,049 | 29,036 | - | 35.7 | 37,478 | Class A Ordinary Shares | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 28,472 | 1,239,585 (1%) | 0% | 0 | Common Stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 556.90 per share. | 08 Feb 2023 | 15,746 | 1,223,839 (1%) | 0% | 556.9 | 8,768,947 | Common Stock |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 30 Dec 2022 | 943 | 27,987 | - | 39.8 | 37,495 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 30 Sep 2022 | 913 | 27,044 | - | 41.1 | 37,490 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 30 Jun 2022 | 903 | 26,131 | - | 41.5 | 37,493 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 24 Jun 2022 | 6,328 | 25,228 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 31 Mar 2022 | 964 | 18,900 | - | 38.9 | 37,471 | Class A Ordinary Shares | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 80,187 | 1,253,573 (1%) | 0% | 0 | Common Stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 550.45 per share. | 07 Feb 2022 | 42,460 | 1,211,113 (1%) | 0% | 550.5 | 23,372,107 | Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Feb 2022 | 7,170 | 7,900 (0%) | 0% | 0 | Common Stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Feb 2022 | 7,170 | 1,676,495 (1%) | 0% | 0 | Common Stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Feb 2022 | 4,275 | 1,683,665 (1%) | 0% | 0 | Common Stock | |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Feb 2022 | 4,275 | 7,900 (0%) | 0% | 0 | Common Stock | |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 30 Sep 2021 | 992 | 16,978 | - | 37.8 | 37,499 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 30 Jun 2021 | 871 | 15,986 | - | 43.0 | 37,489 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 25 Jun 2021 | 5,726 | 15,115 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 31 Mar 2021 | 816 | 9,529 | - | 45.9 | 37,458 | Class A Ordinary Shares | |
| Royalty Pharma PLC (Class A) | Henry A. Fernandez | Director | 25 Feb 2021 | 25,700 | 25,700 | - | 46.8 | 1,203,480 | Class A Ordinary Shares |